Pathology Doctors in Pompton Plains, NJ Accepting Medicare

5 Pathology doctors found. Showing 1 - 5

Stamatina Kaptain, M.D. Pathology - Hematology Medicare: Medicare Enrolled Practice Location: 97 W Parkway, Dept. Of Pathology, Pompton Plains, NJ 07444 Phone: 973-831-5046    Fax: 973-831-5194

Hailing Zhang, M.D. Pathology - Anatomic Pathology & Clinical Pathology Medicare: Accepting Medicare Assignments Practice Location: 97 W Parkway, Dept Of Pathology, Pompton Plains, NJ 07444 Phone: 973-831-5046

Lan Wang, M.D. Pathology - Anatomic Pathology & Clinical Pathology Medicare: Accepting Medicare Assignments Practice Location: 97 W Parkway, Pompton Plains, NJ 07444 Phone: 973-831-5046    Fax: 973-831-5194

Essam A. Ahmed, M.D. Pathology - Anatomic Pathology & Clinical Pathology Medicare: Accepting Medicare Assignments Practice Location: 97 W Parkway, Dept. Of Pathology, Pompton Plains, NJ 07444 Phone: 973-831-5046    Fax: 973-831-5194

Donghong Cai, MD Pathology - Anatomic Pathology & Clinical Pathology Medicare: Medicare Enrolled Practice Location: 97 W Parkway, Pompton Plains, NJ 07444 Phone: 973-831-5000

News Archive

Calcium supplement intake may increase risk of death from heart disease in men

In a new study from the National Institutes of Health, startling results showed that men who took calcium supplements were more apt to die of heart disease than those who didn't get extra calcium in supplement form.

Scientists identify protein that helps map brain tumours

Scientists have discovered a protein that helps map the edge of brain tumours more clearly so they show up on magnetic resonance imaging (MRI) scans, according to new research presented at the National Cancer Research Institute Cancer Conference in Liverpool today.

Diabetic Neuropathy: An interview with Dr Brian Callaghan

Diabetes is the number 1 cause of neuropathy, which is a very common condition in itself. In fact, up to half of all neuropathy is caused by diabetes, although other people can get the condition as well.

Defibrotide drug effective against hepatic veno-occlusive disease

Defibrotide, a novel drug which modulates the response of blood vessels to injury, was markedly more effective than standard treatment in post-stem cell transplant patients with hepatic veno-occlusive disease, a life threatening toxicity of transplant caused by blockages in tiny blood vessels of the liver, according to a study led by Dana-Farber Cancer Institute scientists.

New patent to develop antibody therapies for cancer and other diseases

The University of Rochester Medical Center and Vaccinex, Inc. announced today the award of a key U.S. patent for a technology platform that can assist researchers in finding new treatments for cancer and other diseases. While the technology has many applications, one promising use is for the identification of certain proteins, called monoclonal antibodies, that are capable of seeking out and destroying harmful cells. Several companies have recently developed monoclonal antibodies as treatments for cancer, rheumatoid arthritis, and other conditions. Under an exclusive, worldwide license from the University of Rochester, Vaccinex is using the patented technology to discover and develop new monoclonal antibody therapies.

Read more Medical News

› Verified 7 days ago